1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ZYDUS LIFESCIENCES LTD.

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321

Falling Comet
Download real time

831.65 9.55 (1.16%)

Near 52W Low of ₹795.00

4.3M NSE+BSE Volume

High vol. this week

NSE 17 Apr, 2025 3:22 PM (IST)

Watchlist

Portfolio

Alert

Share
20S
6W
7O
2T
22,247.4

Operating Revenue TTM

High in industry
4,675

Net profit TTM

High in industry
21

Net Profit Margin TTM %

16.9

Operating Revenue growth TTM %

Above industry Median
57.2

Net Profit TTM Growth %

Below industry Median
US FDA Approval
Zydus Life receives final approval from the US FDA to manufacture Jaythari (Deflazacort) tablets See details

Zydus Lifesciences Ltd. Credit Ratings